There are currently more than 150 different COVID-19 vaccines under development. Of these, more than 50 have reached human trials, and seven have been approved for emergency or full use in parts of Europe, North America, and Asia. In the United States, two vaccines—one from the biotechnology company, Moderna and the other from drug giant Pfizer—have been granted an Emergency Use Authorization (EUA) from the FDA. To read the full story.
Recent Posts
- Join NJ ACTS Special Populations Core Seminar Series on 4/30 at 1pm
- NJACTS Community Engagement Core COVID-19 Resources
- Long-Acting Opioids May Be Unnecessary in Study of Total Knee Replacement.
- Predicting Loneliness Through Online Digital Footprints.
- $265K Awarded to NJIT Researchers Via New Jersey Health Foundation Grants.
Categories
- News (2,125)
- Publication (1)